2024 Q1 Form 10-K Financial Statement

#000089817324000009 Filed on February 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $3.976B $3.832B $15.81B
YoY Change 7.24% 5.15% 9.73%
Cost Of Revenue $1.942B $1.865B $7.707B
YoY Change 6.85% 4.14% 9.67%
Gross Profit $2.034B $1.967B $8.105B
YoY Change 7.61% 6.12% 9.8%
Gross Profit Margin 51.16% 51.34% 51.26%
Selling, General & Admin $1.282B $1.249B $4.918B
YoY Change 9.2% 6.57% 11.1%
% of Gross Profit 63.01% 63.47% 60.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $109.6M $112.5M $409.1M
YoY Change 16.96% 12.59% 14.28%
% of Gross Profit 5.39% 5.72% 5.05%
Operating Expenses $1.282B $1.249B $4.918B
YoY Change 9.2% 6.57% 11.1%
Operating Profit $752.5M $718.7M $3.186B
YoY Change 5.0% 5.35% 7.85%
Interest Expense -$55.49M -$54.17M -$196.8M
YoY Change 26.97% 51.75% 36.02%
% of Operating Profit -7.37% -7.54% -6.18%
Other Income/Expense, Net $3.401M $6.963M $15.14M
YoY Change -24.07% -2632.0% -109.72%
Pretax Income $700.4M $671.5M $3.005B
YoY Change 3.39% 3.91% 7.36%
Income Tax $153.2M $119.0M $658.2M
% Of Pretax Income 21.87% 17.72% 21.9%
Net Earnings $547.2M $552.5M $2.347B
YoY Change 5.87% 4.53% 8.01%
Net Earnings / Revenue 13.76% 14.42% 14.84%
Basic Earnings Per Share $9.27 $9.33 $38.80
Diluted Earnings Per Share $9.20 $9.26 $38.47
COMMON SHARES
Basic Shares Outstanding 59.04M 59.16M 60.48M
Diluted Shares Outstanding 59.45M 61.00M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $89.26M $279.1M $279.1M
YoY Change 49.09% 157.07% 157.07%
Cash & Equivalents $89.26M $279.1M $279.1M
Short-Term Investments
Other Short-Term Assets $128.2M $105.3M $105.3M
YoY Change 17.22% -4.59% -4.59%
Inventory $4.805B $4.658B $4.658B
Prepaid Expenses
Receivables $437.8M $375.0M $375.0M
Other Receivables $139.3M $140.4M $140.4M
Total Short-Term Assets $5.600B $5.558B $5.558B
YoY Change 7.94% 10.1% 10.1%
LONG-TERM ASSETS
Property, Plant & Equipment $7.423B $7.238B $7.238B
YoY Change 10.37% 63.6% 10.73%
Goodwill $1.010B $897.7M
YoY Change 13.2% 1.5%
Intangibles $49.77M
YoY Change 7.68%
Long-Term Investments $62.22M
YoY Change 16.69%
Other Assets $180.5M $179.5M $179.5M
YoY Change 8.07% 12.89% 68.18%
Total Long-Term Assets $8.613B $8.315B $8.315B
YoY Change 10.64% 9.7% 9.7%
TOTAL ASSETS
Total Short-Term Assets $5.600B $5.558B $5.558B
Total Long-Term Assets $8.613B $8.315B $8.315B
Total Assets $14.21B $13.87B $13.87B
YoY Change 9.56% 9.86% 9.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.117B $6.092B $6.092B
YoY Change 1.01% 3.58% 3.58%
Accrued Expenses $701.1M $702.3M $702.3M
YoY Change 13.3% 6.4% 6.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.888B $7.661B $7.661B
YoY Change 7.23% 8.46% 8.46%
LONG-TERM LIABILITIES
Long-Term Debt $5.289B $5.570B $5.570B
YoY Change 7.33% 27.41% 27.41%
Other Long-Term Liabilities $2.106B $2.085B $2.085B
YoY Change 2.03% 936.14% 3.86%
Total Long-Term Liabilities $7.395B $7.655B $7.655B
YoY Change 5.76% 67.41% 20.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.888B $7.661B $7.661B
Total Long-Term Liabilities $7.395B $7.655B $7.655B
Total Liabilities $15.60B $15.61B $15.61B
YoY Change 6.89% 34.16% 14.05%
SHAREHOLDERS EQUITY
Retained Earnings -$2.849B -$3.132B
YoY Change -3.51% 31.81%
Common Stock $1.411B $1.353B
YoY Change 8.08% 3.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.391B -$1.739B -$1.739B
YoY Change
Total Liabilities & Shareholders Equity $14.21B $13.87B $13.87B
YoY Change 9.56% 9.86% 9.86%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $547.2M $552.5M $2.347B
YoY Change 5.87% 4.53% 8.01%
Depreciation, Depletion And Amortization $109.6M $112.5M $409.1M
YoY Change 16.96% 12.59% 14.28%
Cash From Operating Activities $704.2M $516.4M $3.034B
YoY Change -1.34% -35.06% -3.63%
INVESTING ACTIVITIES
Capital Expenditures $249.2M $252.3M $1.006B
YoY Change 11.63% 44.55% 78.62%
Acquisitions
YoY Change
Other Investing Activities -$151.5M $6.128M $10.33M
YoY Change -8767.79% -103.37% 226.42%
Cash From Investing Activities -$400.8M -$246.1M -$995.9M
YoY Change 80.91% -30.92% 34.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$3.060B
YoY Change -193.22%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -493.6M -74.04M -1.869B
YoY Change -8.88% -81.4% -29.81%
NET CHANGE
Cash From Operating Activities 704.2M 516.4M 3.034B
Cash From Investing Activities -400.8M -246.1M -995.9M
Cash From Financing Activities -493.6M -74.04M -1.869B
Net Change In Cash -190.1M 196.2M 169.4M
YoY Change 284.66% 380.08% -166.82%
FREE CASH FLOW
Cash From Operating Activities $704.2M $516.4M $3.034B
Capital Expenditures $249.2M $252.3M $1.006B
Free Cash Flow $455.0M $264.1M $2.028B
YoY Change -7.24% -57.45% -21.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000898173
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 orly Non Financial Assets And Liabilities Fair Value Nonrecurring
NonFinancialAssetsAndLiabilitiesFairValueNonrecurring
0
CY2023Q4 orly Non Financial Assets And Liabilities Fair Value Nonrecurring
NonFinancialAssetsAndLiabilitiesFairValueNonrecurring
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
0
CY2023Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
0
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 us-gaap Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense
CY2022 us-gaap Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense
CY2023 us-gaap Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense
CY2022 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2023 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2023 dei Entity Registrant Name
EntityRegistrantName
O Reilly Automotive Inc
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62353221
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59072792
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MO
CY2023 dei Entity File Number
EntityFileNumber
000-21318
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-4358837
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
233 South Patterson Avenue
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Springfield
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
MO
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
65802
CY2023 dei City Area Code
CityAreaCode
417
CY2023 dei Local Phone Number
LocalPhoneNumber
862-6708
CY2023 dei Security12b Title
Security12bTitle
Common Stock
CY2023 dei Trading Symbol
TradingSymbol
ORLY
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
48266172701
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59036585
CY2023 dei Auditor Firm
AuditorFirmId
42
CY2023 dei Auditor Firm
AuditorFirmId
42
CY2023 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2023 dei Auditor Location
AuditorLocation
Kansas City, Missouri
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
279132000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108583000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
15834000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14695000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
375049000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
343155000
CY2023Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
140443000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
127019000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000
CY2023Q4 us-gaap Inventory Net
InventoryNet
4658367000
CY2022Q4 us-gaap Inventory Net
InventoryNet
4359126000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
105311000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
110376000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
5558302000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5048259000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8312367000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7438065000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3275387000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3014024000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5036980000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4424041000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2200554000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2112267000
CY2023Q4 us-gaap Goodwill
Goodwill
897696000
CY2022Q4 us-gaap Goodwill
Goodwill
884445000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
179463000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
158967000
CY2023Q4 us-gaap Assets
Assets
13872995000
CY2022Q4 us-gaap Assets
Assets
12627979000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6091700000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5881157000
CY2023Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
128548000
CY2022Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
138926000
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
138122000
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
126888000
CY2023Q4 orly Accrued Benefits And Withholdings
AccruedBenefitsAndWithholdings
174650000
CY2022Q4 orly Accrued Benefits And Withholdings
AccruedBenefitsAndWithholdings
166433000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7860000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
389536000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
366721000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
730937000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
383692000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7661353000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7063817000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5570125000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4371653000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1881344000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1806656000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
295471000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
245347000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
203980000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
201258000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
245000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59072792
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62353221
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
591000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
624000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1352275000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1311488000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3131532000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2375860000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
39388000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2996000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1739278000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1060752000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13872995000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12627979000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15812250000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14409860000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13327563000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7707447000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7028154000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6307614000
CY2023 us-gaap Gross Profit
GrossProfit
8104803000
CY2022 us-gaap Gross Profit
GrossProfit
7381706000
CY2021 us-gaap Gross Profit
GrossProfit
7019949000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4918427000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4427215000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4102781000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
3186376000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
2954491000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
2917168000
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
201668000
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
157720000
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
144768000
CY2023 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
4900000
CY2022 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
4763000
CY2021 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1971000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15142000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2879000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7543000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-181626000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-155836000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-135254000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3004750000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2798655000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2781914000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
658169000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
626005000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
617229000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2346581000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2172650000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2164685000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
38.80
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
33.75
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
31.39
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60475000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64372000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68967000
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
38.47
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
33.44
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
31.10
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60998000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64962000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69611000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2346581000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2172650000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2164685000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
36392000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9795000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4644000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
36392000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9795000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4644000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2382973000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2182445000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2160041000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
140258000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2164685000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4644000
CY2021 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
18511000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
67761000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23054000
CY2021 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2476048000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-66423000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2172650000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9795000
CY2022 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
19864000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
60977000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24650000
CY2022 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3282265000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1060752000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2346581000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
36392000
CY2023 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
21691000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71153000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25642000
CY2023 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3151155000
CY2023 us-gaap Stockholders Equity Other
StockholdersEquityOther
28830000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1739278000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2346581000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2172650000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2164685000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
409061000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
357933000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
328217000
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4954000
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4704000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4388000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
48232000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
69575000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
20383000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
27511000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
26458000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
24656000
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2116000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-885000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2128000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35539000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
75859000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
47427000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
288323000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
669046000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32634000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
207061000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1184858000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
510911000
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
33889000
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
151063000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
152339000
CY2023 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
11234000
CY2022 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
19300000
CY2021 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
18714000
CY2023 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-12763000
CY2022 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-60072000
CY2021 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
9214000
CY2023 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-280070000
CY2022 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
34199000
CY2021 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-51736000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3034084000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3148250000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3207310000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1006264000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
563342000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
442853000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17689000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
14803000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
9494000
CY2023 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
4150000
CY2022 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
188282000
CY2021 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
180333000
CY2023 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3211000
CY2022 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3164000
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1928000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-995936000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-739985000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-615620000
CY2023 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
3227000000
CY2022 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
785800000
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0
CY2023 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
3227000000
CY2022 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
785800000
CY2021 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0
CY2023 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
746789000
CY2022 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
0
CY2021 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
0
CY2023 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
749655000
CY2022 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
847314000
CY2021 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0
CY2023 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
300000000
CY2022 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
300000000
CY2021 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
300000000
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4989000
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6591000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3412000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3151155000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3282265000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2476048000
CY2023 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
91316000
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
79356000
CY2021 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
84915000
CY2023 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-354000
CY2022 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-350000
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-313000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1868738000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2662536000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2694858000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1139000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
741000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-359000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
170549000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-253530000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-103527000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108583000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
362113000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
465640000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
279132000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108583000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
362113000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
315060000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
415165000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
450935000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
189611000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
155853000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
144293000
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 3pt 0pt;"><i style="font-style:italic;">Nature of business:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">O’Reilly Automotive, Inc. and Subsidiaries, collectively, “O’Reilly” or the “Company,” is a specialty retailer and supplier of automotive aftermarket parts.  The Company’s stores carry an extensive product line, including new and remanufactured automotive hard parts, maintenance items, and various automotive accessories.  As of December 31, 2023, the Company owned and operated 6,095 stores in 48 U.S. states and Puerto Rico and 62 stores in Mexico, servicing both do-it-yourself (“DIY”) and the professional service provider customers.  The Company’s robust distribution system provides stores with same-day or overnight access to an extensive inventory of hard-to-find items not typically stocked in the stores of other auto parts retailers.</p>
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 3pt 0pt;"><i style="font-style:italic;">Use of estimates:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The preparation of the consolidated financial statements, in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”), requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes.  Actual results could materially differ from those estimates.</p>
CY2023 orly Replacement Cost Of Inventory
ReplacementCostOfInventory
4940000000
CY2022 orly Replacement Cost Of Inventory
ReplacementCostOfInventory
4700000000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 orly Self Insurance Reserves Undiscounted
SelfInsuranceReservesUndiscounted
225740000
CY2022Q4 orly Self Insurance Reserves Undiscounted
SelfInsuranceReservesUndiscounted
245562000
CY2023Q4 orly Self Insurance Reserves Discounted
SelfInsuranceReservesDiscounted
214116000
CY2022Q4 orly Self Insurance Reserves Discounted
SelfInsuranceReservesDiscounted
233017000
CY2023Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
128500000
CY2022Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
138900000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
85700000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
81500000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
72500000
CY2023 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
7200000
CY2022 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
5500000
CY2021 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
7000000.0
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
25500000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
24700000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7100000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6300000
CY2023 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
8400000
CY2022 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-8300000
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
59508000
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
49371000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14695000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
11870000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7261000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6718000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6226000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3928000
CY2023 orly Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
104000
CY2022 orly Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
35000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
15834000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14695000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8312367000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7438065000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3275387000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3014024000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5036980000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4424041000
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2200000
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
7600000
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
12600000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
398537000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
367724000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
351296000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
9508000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
11314000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
7694000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
99911000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
93940000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
89065000
CY2023 us-gaap Sublease Income
SubleaseIncome
4805000
CY2022 us-gaap Sublease Income
SubleaseIncome
5220000
CY2021 us-gaap Sublease Income
SubleaseIncome
4571000
CY2023 us-gaap Lease Cost
LeaseCost
503151000
CY2022 us-gaap Lease Cost
LeaseCost
467758000
CY2021 us-gaap Lease Cost
LeaseCost
443484000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
390907000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
366866000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
387810000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
416615000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
390167000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
369817000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
333610000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
284972000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
232426000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1115802000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2726794000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
455914000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2270880000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
389536000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1881344000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y4M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.043
CY2022Q4 orly Goodwill And Acquisition Intangibles
GoodwillAndAcquisitionIntangibles
884445000
CY2021Q4 orly Goodwill And Acquisition Intangibles
GoodwillAndAcquisitionIntangibles
879340000
CY2023 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
1989000
CY2022 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
1452000
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
11262000
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
3653000
CY2023Q4 orly Goodwill And Acquisition Intangibles
GoodwillAndAcquisitionIntangibles
897696000
CY2022Q4 orly Goodwill And Acquisition Intangibles
GoodwillAndAcquisitionIntangibles
884445000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22064000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13787000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8277000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
27988000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17903000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10085000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
63557000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13787000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
49770000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
64122000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17903000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46219000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000.0
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4800000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4900000
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2022 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2023 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1620000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1613000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1588000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1448000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1088000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
920000
CY2023Q4 orly Finite Lived Intangible Assets Amortization Five Years
FiniteLivedIntangibleAssetsAmortizationFiveYears
8277000
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4400000000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4200000000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5600900000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4400000000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
30775000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
28347000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5570125000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4371653000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
750900000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1250000000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
750000000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
500000000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
2350000000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5600900000
CY2023 us-gaap Line Of Credit Facility Covenant Compliance
LineOfCreditFacilityCovenantCompliance
As of December 31, 2023, the Company remained in compliance with all covenants under the Credit Agreement.
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
456945000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y2M12D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
388517000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
98564000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
77199000
CY2023 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
180971000
CY2022 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
152777000
CY2023 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
200228000
CY2022 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
174118000
CY2023 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
74000
CY2022 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
24000
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
117895000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
98564000
CY2022Q4 orly Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
1500000000
CY2023Q2 orly Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
2000000000.0
CY2023Q4 orly Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
2000000000.0
CY2023Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25800000000
CY2022Q4 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2023Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2023Q4 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2023 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3568000
CY2022 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
4961000
CY2023 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
883.13
CY2022 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
661.66
CY2023 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
3151120000
CY2022 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
3282215000
CY2023Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2600000000
CY2023 us-gaap Stockholders Equity Other
StockholdersEquityOther
28800000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15812250000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14409860000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13327563000
CY2023 orly Schedule Of Common Shares Available For Future Issuance Under Benefit And Compensation Plans
ScheduleOfCommonSharesAvailableForFutureIssuanceUnderBenefitAndCompensationPlans
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:46.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:24.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:24.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:50.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Shares Authorized for</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares Available for Future</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Plans</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Issuance under the Plans</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Issuance under the Plans</b></p></td></tr><tr><td style="vertical-align:bottom;width:46.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Incentive Plans</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 35,650</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,492</p></td></tr><tr><td style="vertical-align:bottom;width:46.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Employee Stock Purchase Plan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 412</p></td></tr><tr><td style="vertical-align:bottom;width:46.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Profit Sharing and Savings Plan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,200</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 349</p></td></tr></table>
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
461145000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y2M12D
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2994856000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2786866000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2770485000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
9894000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
11789000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
11429000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3004750000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2798655000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2781914000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
497492000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
455779000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
485988000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
109924000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
95388000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
104837000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2521000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5263000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
6021000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
609937000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
556430000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
596846000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
41782000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
62719000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
20543000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
6003000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
8583000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2432000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
447000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1727000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-2592000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
48232000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
69575000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
20383000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
658169000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
626005000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
617229000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
630998000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
587716000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
584202000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
98254000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
87352000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
90360000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-35950000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-25503000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-35202000
CY2023 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
19627000
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
17593000
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
18592000
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-15506000
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-5967000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-3539000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
658169000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
626005000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
617229000
CY2023 us-gaap Investment Tax Credit
InvestmentTaxCredit
336500000
CY2022 us-gaap Investment Tax Credit
InvestmentTaxCredit
167600000
CY2022 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
663.36
CY2021 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
479.90
CY2021 us-gaap Investment Tax Credit
InvestmentTaxCredit
177100000
CY2023Q4 orly Liability For Purchase Of Transferrable Federal Renewable Energy Tax Credits
LiabilityForPurchaseOfTransferrableFederalRenewableEnergyTaxCredits
266000000.0
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
2430000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
2196000
CY2023Q4 orly Deferred Tax Assets Deferred Expense Reserves And Accruals Other Current
DeferredTaxAssetsDeferredExpenseReservesAndAccrualsOtherCurrent
150483000
CY2022Q4 orly Deferred Tax Assets Deferred Expense Reserves And Accruals Other Current
DeferredTaxAssetsDeferredExpenseReservesAndAccrualsOtherCurrent
137474000
CY2023Q4 orly Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
559830000
CY2022Q4 orly Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
538890000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
18102000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
17115000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
730845000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
695675000
CY2023Q4 orly Deferred Tax Liability Current Inventory
DeferredTaxLiabilityCurrentInventory
142578000
CY2022Q4 orly Deferred Tax Liability Current Inventory
DeferredTaxLiabilityCurrentInventory
104572000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
280791000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
233288000
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
540359000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
521541000
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
62588000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
81621000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1026316000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
941022000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
295471000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
245347000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24798000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
26847000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3707864000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4068991000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4203380000
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3832015000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
30967000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3932000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4146000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
5446000
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
1000000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
2570000
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
4787000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
5195000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
6996000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23943000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24798000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
26847000
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
21900000
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
22400000
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
24200000
CY2023Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3900000
CY2022Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3500000
CY2021Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3800000
CY2023 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
2100000
CY2022 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
1500000
CY2021 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
1600000
CY2023Q4 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
7300000
CY2023 us-gaap Open Tax Year
OpenTaxYear
2020
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2346581000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2172650000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
2164685000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60475000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64372000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68967000
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
523000
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
590000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
644000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60998000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64962000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69611000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
38.80
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
33.75
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
31.39
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
38.47
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
33.44
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
31.10
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
95000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
144000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
111000
CY2023 orly Share Based Compensation Arrangement By Share Based Payment Award Options Antidilutive In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAntidilutiveInPeriodWeightedAverageExercisePrice
836.12
CY2023Q1 us-gaap Gross Profit
GrossProfit
1890329000
CY2023Q2 us-gaap Gross Profit
GrossProfit
2086582000
CY2023Q3 us-gaap Gross Profit
GrossProfit
2160463000
CY2023Q4 us-gaap Gross Profit
GrossProfit
1967429000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
716645000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
853773000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
897222000
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
718736000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
516885000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
627365000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
649827000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
552504000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.36
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
10.32
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
10.82
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.33
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.28
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.22
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.72
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.26
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3296011000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3670737000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3798619000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3644493000
CY2022Q1 us-gaap Gross Profit
GrossProfit
1708072000
CY2022Q2 us-gaap Gross Profit
GrossProfit
1884718000
CY2022Q3 us-gaap Gross Profit
GrossProfit
1934962000
CY2022Q4 us-gaap Gross Profit
GrossProfit
1853954000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
669530000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
798550000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
804194000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
682217000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
481880000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
576760000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
585438000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
528572000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.24
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.86
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.25
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.45
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.17
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.78
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.17
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.37
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000898173-24-000009-index-headers.html Edgar Link pending
0000898173-24-000009-index.html Edgar Link pending
0000898173-24-000009.txt Edgar Link pending
0000898173-24-000009-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orly-20231231.xsd Edgar Link pending
orly-20231231x10k.htm Edgar Link pending
orly-20231231x10k003.jpg Edgar Link pending
orly-20231231x10k007.jpg Edgar Link pending
orly-20231231xex21d1.htm Edgar Link pending
orly-20231231xex23d1.htm Edgar Link pending
orly-20231231xex31d1.htm Edgar Link pending
orly-20231231xex31d2.htm Edgar Link pending
orly-20231231xex32d1.htm Edgar Link pending
orly-20231231xex32d2.htm Edgar Link pending
orly-20231231xex97d1.htm Edgar Link pending
orly-20231231xex97d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
orly-20231231_cal.xml Edgar Link unprocessable
orly-20231231_def.xml Edgar Link unprocessable
orly-20231231_lab.xml Edgar Link unprocessable
orly-20231231_pre.xml Edgar Link unprocessable
orly-20231231x10k_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable